Teleflex Incorporated (TFX) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, ma...
Teleflex Incorporated's revenue decreased 34.6% year over year, from $3.05B to $1.99B.
Net income decreased 1399.8% over the same period, from $69.7M to $-905.6M.
Over the 9-year period from FY2016 to FY2025, revenue grew by 7% in total.
Total debt increased by 59.5% to $2.64B.
The debt-to-equity ratio stands at 0.85, indicating a moderate leverage profile.
Operating cash flow declined 84.9% to $96.7M.
Teleflex Incorporated maintains a negative net profit margin of -45.4%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $2.20B+51.3% | $325.2M | $1.22B | $423.8M | $372.4M | $7.49B | $2.04B | $4.31B |
| Q1 FY2024 | $737.8M-66.5% | $15.3M | $416.1M | $-4.8M | $112.8M | $7.48B | $1.76B | $4.50B |
| Q2 FY2024 | $1.49B+101.6% | $95.3M | $832.6M | $112.1M | $204.5M | $7.44B | $1.72B | $4.56B |
| Q3 FY2024 | $2.25B+51.4% | $206.3M | $1.26B | $261.4M | $435.6M | $7.49B | $1.76B | $4.48B |
| Q1 FY2025 | $700.7M-68.9% | $95.0M | $389.4M | $125.6M | $73.3M | $7.16B | $1.91B | $4.10B |
| Q2 FY2025 | $1.48B+111.4% | $217.6M | $820.5M | $280.9M | $81.2M | $7.38B | $1.90B | $4.24B |
| Q3 FY2025 | $2.39B+61.6% | $-191.3M | $1.27B | $-128.0M | $189.0M | $7.87B | $2.67B | $3.82B |
| Q1 FY2026 | $548.3M-77.1% | $-8.2M | $307.4M | $20.2M | $46.7M | $6.78B | $2.62B | $3.08B |
Balance Sheet Summary (Latest Period)
Total Assets
$6.95B
Total Liabilities
$3.82B
Total Equity
$3.12B
Cash & Equivalents
$378.6M
Total Debt
$2.64B
Current Assets
$1.94B
Current Liabilities
$762.0M
Retained Earnings
$3.15B